Bree C. Peterson | White & Case LLP International Law Firm, Global Law Practice

Bree C. Peterson

Associate, London

T +44 20 7532 1432



Bree Peterson is an associate in the Firm's Capital Markets group in London.

Bree's practice includes representing investment banks and issuers on a range of cross-border capital markets transactions, including SEC registered public offerings, Rule 144A/Reg S offerings, venture capital investments and other public and private financings. Bree also has experience in cross-border mergers and acquisitions, Exchange Act reporting for US public companies and foreign private issuers, and complex global corporate and tax reorganizations.

Prior to joining White & Case, Bree practiced in prominent US law firms in London and Minneapolis.

Bars and Courts

  • Minnesota State Bar


  • JD, University of St. Thomas
  • BA, International Relations, University of San Diego


  • English


Counsel to Kaupthing hf., an Icelandic bank, on aspects of its restructuring following its $45 billion insolvency.

Counsel to Afren plc, the Africa-focused oil exploration and production company, on aspects of its corporate restructuring involving amendments to secured facilities, bond restructurings, equity offerings and amendments of interests in its underlying oil & gas assets.

Advising J.P Morgan Cazenove, Bank of America Merrill Lynch and RBC Capital Markets as underwriters in connection with the rights issue of Hochschild Mining PLC, a precious metal group operating in Latin America and listed on the London Stock Exchange.

Advising Guggenheim Securities, Bryan, Garnier & Co and Needham & Company, LLC as placement agents in the €27 million private placement of ordinary shares of Nicox S.A., an international ophthalmic company listed on Euronext Paris.

Advising Summit Therapeutics plc, an AIM-listed clinical stage drug discovery and development company, in its initial public offering on Nasdaq.*

Advising Leerink Partners, Deutsche Bank and JMP Securities as underwriters in connection with the initial public offering of ProQR Therapeutics N.V., a biopharmaceutical company engaged in development of RNA-based therapeutics, on Nasdaq.*

Advising uniQure N.V., a gene therapy company, in its initial public offering on Nasdaq.*

Advising Yandex N.V., one of the largest European internet companies and the leading search provider in Russia, in a $690 million offering of convertible senior notes (Rule 144A/Reg S).*

Advising CTC Media, lnc., Yandex N.V. and uniQure N.V. in U.S. public company compliance and Exchange Act reporting matters.*

Underwriters' counsel in public offerings for CUI Global, Inc., Enteromedics Inc., Odyssey Marine Exploration, and MagneGas Corp.*

Counsel to issuers, investors and placement agents in private placements, including PIPEs and venture capital financing transactions.

Counsel to depositaries in connection with implementation of American Depositary Shares facilities for U.S. offerings.

*Matters prior to joining White & Case